Mn. Starkman et al., Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease, BIOL PSYCHI, 46(12), 1999, pp. 1595-1602
Background: Decreased hippocampal volume is observed in patients with Cushi
ng's syndrome and other conditions associated with elevated cortisol levels
, stress, or both. Reversibility of hippocampal neuronal atrophy resulting
from stress occurs in animals. Our study investigated the potential for rev
ersibility of human hippocampal atrophy.
Methods: The study included 22 patients with Gushing's disease. Magnetic re
sonance brain imaging was performed prior to transsphenoidal microadenomect
omy and again after treatment.
Results: Following treatment, hippocampal formation volume (HFV) increased
by up to 10%. The mean percent change (3.2 +/- 2.5) was significantly great
er (p < .04) than that of the comparison structure, caudate head volume (1.
5 +/- 3.4). Increase in HFV was significantly associated with magnitude of
deer-ease in urinary free cortisol (r = -.61, p < .01). This relationship s
trengthened after adjustments for age, duration of disease, and months elap
sed since surgery (r = -.70, p < .001). There was no significant correlatio
n between caudate head volume change and magnitude of cortisol decrease.
Conclusions: Changes in human HFV associated with sustained hypercortisolem
ia are reversible, at least in part, once cortisol levels decrease. While m
any brain regions are likely affected by hypercortisolemia, the human hippo
campus exhibits increased sensitivity to cortisol, affecting both volume lo
ss and recovery. Biol Psychiatry 1999;46:1595-1602 (C) 1999 Society of Biol
ogical Psychiatry.